U.S. Markets close in 5 hrs 55 mins

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.96+0.42 (+0.99%)
As of 10:04AM EDT. Market open.
People also watch
Full screen
Previous Close42.54
Bid42.90 x 300
Ask42.98 x 200
Day's Range42.24 - 43.08
52 Week Range23.51 - 63.73
Avg. Volume2,407,093
Market Cap2.36B
PE Ratio (TTM)-17.74
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • This Biotech Got A Price Hike, But Seesawed After A Three-Day Run
    Investor's Business Daily2 days ago

    This Biotech Got A Price Hike, But Seesawed After A Three-Day Run

    Sarepta stock toed the line Monday after a three-day run turned negative following its strong second-quarter report last week and a price-target hike.

  • American City Business Journals2 days ago

    Sarepta may look to bolster pipeline after $250M offering

    Sarepta Therapeutics is planning to raise up to $250 million in a new stock offering, and said it may use some of the proceeds to acquire or license additional drug candidates. The company said that new CEO Douglas Ingram is interested in buying up to $2 million worth of the shares. Proceeds from the offering could be used to license or acquire “complementary products and technologies,” or for a range of other purposes, including to fund clinical trials, commercialization activities and manufacturing, Sarepta said.

  • Barrons.com4 days ago

    [$$] Sarepta's Sales Ramp Up

    The new CEO of Sarepta Therapeutics, pharma industry veteran Douglas Ingram, is bullish on the company’s prospects, and Wall Street is starting to see it his way. Sarepta shares (SRPT) surged 22% last ...